Article
Genetic profile considerations for induction of allogeneic chimerism as a therapeutic approach for type 1 diabetes mellitus.
Drug discovery today - 1 Aug 2020
Black Labe A, Zorina Tatiana
Abstract excerpt
The major therapeutic modality for type 1 diabetes mellitus (T1DM) remains sustaining euglycemia by exogenous administration of insulin. Based on a new understanding of bone marrow structural and functional dynamics, a conditioning-free bone marrow transplantation (BMT), with reduced adverse effects, opens the possibility for evaluating β cell regeneration and restoration of euglycemia by induction of allogeneic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
